LunGinnov

LunGinnov offers innovative solutions for research and the diagnosis of endothelial dysfunctions.

Our company develops, manufactures, and markets laboratory reagents (monoclonal antibodies, recombinant proteins, ELISA kits, etc.) for the detection and study of endothelial dysfunctions.

We sell our products directly in France, Europe, and the United States. We use partners (importers and distributors) in certain regions of the world. To view our list of distributors.

Advancing biotechnology to improve human life.

We are committed to using biotechnology to benefit both people and the environment.

Decoding Endothelial Health: Precision Tools for Vascular Research & Diagnosis

Monoclonal antibodies, recombinant proteins & ELISA kits engineered to unravel endothelial dysfunction – from mechanistic studies to clinical insights.

Join the growing number of clients who trust us to deliver cutting-edge biotech solutions.

Get in touch with us

Custom Assay Development

Bespoke solutions for pre-clinical/clinical endothelial studies.

Recombinant Proteins

GMP-grade cytokines (VEGF, TNF-α) & adhesion molecules for functional assays.

Monoclonal Antibodies

High-affinity clones targeting endothelial markers (ICAM-1, VE-Cadherin, eNOS) – validated for IHC, flow cytometry & WB

ELISA Kits

Quantify endothelial dysfunction biomarkers (ET-1, sICAM, vWF) with ≤5% CV inter-assay precision.

Where Science Meets Precision in Vascular Health

Cutting-edge solutions for endothelial dysfunction research and diagnosis.

Why Researchers Trust LunGinnov

Antibodies with 90-110% recovery in spike-and-recovery assays

ELISAs validated against human serum/plasma matrices

Lot-to-lot consistency guaranteed

Technical support with experimental design

- Sepsis & Inflammation
- Diabetes-Associated Vasculopathy
- Rare Vascular Diseases

Precision tools for researchers and clinicians tackling endothelial disease.

Tailored solutions for research labs and healthcare providers